50 studies found for:    NIAID | Recruiting | Exclude Unknown | allergy OR asthma OR diabetes OR transplant OR multiple sclerosis OR psoriatic arthritis OR lupus
Show Display Options
Rank Status Study
21 Recruiting Optimization of NULOJIX® (Belatacept) Usage as a Means of Minimizing CNI Exposure in Simultaneous Pancreas and Kidney Transplantation
Condition: Pancreas and Kidney Transplant
Interventions: Biological: Belatacept;   Drug: methylprednisolone;   Biological: Anti-thymocyte Globulin;   Drug: Tacrolimus;   Drug: Mycophenolate mofetil
22 Recruiting Baked Egg or Egg Oral Immunotherapy for Children With Egg Allergy
Condition: Food Allergy
Interventions: Drug: Egg Oral Immunotherapy;   Drug: Baked Egg
23 Recruiting Chitinases and Transforming Growth Factor Beta (TGFB) in Human Asthma
Condition: Asthma
Intervention:
24 Recruiting A Randomized, Double-Blind, Placebo-Controlled Study of Omalizumab for Idiopathic Anaphylaxis
Conditions: Anaphylaxis;   Hypotension;   Bronchospasm;   Angioedema
Interventions: Drug: Epinephrine;   Procedure: Bone Marrow Apsiration;   Drug: Omalizumab (Xolair)
25 Recruiting Tolerance Following Peanut Oral Immunotherapy
Condition: Peanut Allergy
Interventions: Drug: Peanut Flour;   Drug: Oat Flour
26 Recruiting Genomics of Kidney Transplantation
Condition: Kidney Transplantation
Intervention:
27 Recruiting Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 1
Intervention: Drug: Oral Insulin
28 Recruiting Natural History Study of the Development of Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Intervention:
29 Recruiting Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"
Conditions: Autoantibody Positive;   Non-diabetic Relatives at Risk for Type 1 Diabetes;   High Risk;   Impaired Glucose Tolerance
Intervention: Drug: Teplizumab
30 Recruiting CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1
Conditions: Abnormal Glucose Tolerance;   Type 1 Diabetes
Interventions: Drug: CTLA4-Ig (Abatacept);   Drug: Placebo
31 Recruiting Study of the Complications Associated With Certain Stem Cell Transplants
Condition: Stem Cell Transplantation
Intervention:
32 Recruiting Research Study of ATG and Rituximab in Renal Transplantation
Condition: Acute Kidney Injury
Interventions: Drug: ATG;   Drug: Rituximab;   Drug: Tacrolimus;   Drug: Sirolimus;   Drug: MMF
33 Recruiting Cause of Unexplained Anaphylaxis
Condition: Anaphylaxis
Intervention:
34 Recruiting Validation of Gene Expression Markers of Renal Allograft Functional Decline
Condition: Kidney Transplantation
Intervention:
35 Recruiting Interferon Responses in Eczema Herpeticum (ADEH)
Conditions: Atopic Dermatitis;   Eczema Herpeticum;   Herpes Simplex Infections;   Eczema Vaccinatum
Intervention:
36 Recruiting Normal Blood, Bone Marrow and Buccal Mucosa Protocol
Condition: Healthy
Intervention:
37 Recruiting Delayed Tolerance in Recipients of Living Kidney Allografts by Donor FCRx Infusion
Condition: Kidney Transplantation
Intervention: Biological: Hematopoietic Stem Cell Transplant/novel platform technology
38 Recruiting Safety Study of Cord Blood Units for Stem Cell Transplants
Conditions: Aplastic Anemia;   Leukemia;   Myelodysplastic Syndrome (MDS);   Lymphoma
Intervention: Procedure: Cord Blood Units
39 Recruiting Thymus Transplantation Safety-Efficacy
Conditions: Complete DiGeorge Anomaly;   DiGeorge Syndrome;   DiGeorge Anomaly;   Complete DiGeorge Syndrome
Interventions: Biological: Thymus  Tissue for Transplantation;   Procedure: Blood Draw;   Drug: Rabbit anti-thymocyte globulin;   Drug: Cyclosporine;   Drug: Tacrolimus;   Drug: Methylprednisolone or Prednisolone;   Drug: Basiliximab;   Drug: Mycophenolate mofetil
40 Recruiting Pathogenesis of Physical Induced Urticarial Syndromes
Conditions: Autoinflammatory Syndromes;   Physical Urticaria
Intervention:

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-50) Show next page of results
Indicates status has not been verified in more than two years